Sort
10,766 grants matching “checkpoint inhibitor”
Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases
$839,968Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2020 · AI
Advancing treatment and understanding of immunotherapy in glioblastoma
$838,812Nicholas A Butowski · University Of California, San Francisco · U19 · FY2025 · CA
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques
$837,286Guido Silvestri · Emory University · R01 · FY2020 · AI
Spatiotemporal checkpoints of macrophages in aortic aneurysms- Renewal
$836,972Bhama Ramkhelawon · New York University School Of Medicine · R01 · FY2024 · HL
Development of a potent and selective oral ENPP1 inhibitor for oncology
$836,231Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2023 · CA
Immune determinants modulating cancer development in Lynch Syndrome
$836,028Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · UG3 · FY2025 · CA
Immune determinants modulating cancer development in Lynch Syndrome
$836,028Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · UG3 · FY2024 · CA
Clinical trials employing cancer vaccine combination therapies
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identification of human tumor-associated antigens
$835,772Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Polysaccharides In Morphogenesis
$835,507Enrico Cabib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques
$835,203Guido Silvestri · Emory University · R01 · FY2019 · AI
Initiation Of DNA Replication In Mammalian Chromosomes
$834,809Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Radiation-induced translational control of gene expression
$834,513Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Software for predicting liver injury from biologics drug candidates using data from a human liver microphysiology system
$834,404Kyunghee Yang · Simulations Plus, Inc. · R44 · FY2023 · TR
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$833,492Javid J Moslehi · Vanderbilt University Medical Center · R01 · FY2021 · HL
Regulation of Ras-Dependent Signal Transduction Pathways
$832,699Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$832,061Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · HL
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2022 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$828,114Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · CA
Spatiotemporal checkpoints of macrophages in aortic aneurysms- Renewal
$826,506Bhama Ramkhelawon · New York University School Of Medicine · R01 · FY2025 · HL